SG11201703944XA - Phospholipid preparations for the improvement of communication skills - Google Patents

Phospholipid preparations for the improvement of communication skills

Info

Publication number
SG11201703944XA
SG11201703944XA SG11201703944XA SG11201703944XA SG11201703944XA SG 11201703944X A SG11201703944X A SG 11201703944XA SG 11201703944X A SG11201703944X A SG 11201703944XA SG 11201703944X A SG11201703944X A SG 11201703944XA SG 11201703944X A SG11201703944X A SG 11201703944XA
Authority
SG
Singapore
Prior art keywords
improvement
communication skills
phospholipid preparations
phospholipid
preparations
Prior art date
Application number
SG11201703944XA
Other languages
English (en)
Inventor
Regev Daphna Zaaroor
Robert Chudnow
Yael Richter
Artzi Gali Olga Soria
Original Assignee
Enzymotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzymotec Ltd filed Critical Enzymotec Ltd
Publication of SG11201703944XA publication Critical patent/SG11201703944XA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201703944XA 2014-11-20 2015-11-19 Phospholipid preparations for the improvement of communication skills SG11201703944XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462082261P 2014-11-20 2014-11-20
PCT/IB2015/002391 WO2016079595A2 (en) 2014-11-20 2015-11-19 Phospholipid preparations for the improvement of communication skills

Publications (1)

Publication Number Publication Date
SG11201703944XA true SG11201703944XA (en) 2017-06-29

Family

ID=54337183

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201703944XA SG11201703944XA (en) 2014-11-20 2015-11-19 Phospholipid preparations for the improvement of communication skills

Country Status (12)

Country Link
US (1) US20170360812A1 (enrdf_load_stackoverflow)
EP (1) EP3220753B1 (enrdf_load_stackoverflow)
JP (1) JP6787891B2 (enrdf_load_stackoverflow)
KR (1) KR102409134B1 (enrdf_load_stackoverflow)
CN (1) CN107249581B (enrdf_load_stackoverflow)
AU (1) AU2015348010B2 (enrdf_load_stackoverflow)
CA (1) CA2967895C (enrdf_load_stackoverflow)
ES (1) ES2745226T3 (enrdf_load_stackoverflow)
IL (1) IL252302B (enrdf_load_stackoverflow)
NZ (1) NZ733019A (enrdf_load_stackoverflow)
SG (1) SG11201703944XA (enrdf_load_stackoverflow)
WO (1) WO2016079595A2 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117918425B (zh) * 2024-03-05 2025-01-24 广州迪卡德营养科技有限公司 一种提高记忆学习功能的神经酸组合物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10149108A1 (de) * 2001-10-05 2003-04-30 Degussa Bioactives Deutschland Verwendung von Phosphatidylserin zur Behandlung des Aufmerksamkeits-Defizit-Syndroms (ADHS)
IL158553A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Method for preparing phosphatidylserine containing omega-3 acid moieties
US7935365B2 (en) * 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
IL158552A0 (en) * 2003-10-22 2004-05-12 Enzymotec Ltd Lipids containing omega-3 fatty acids
ATE428312T1 (de) * 2004-01-29 2009-05-15 Indena Spa Verwendung von ginkgokomplexen zur verbesserung von kognitiven leistungen und linderung der mentalen ermüdung
KR20120051458A (ko) * 2010-11-12 2012-05-22 주식회사 두산 크릴 인지질을 이용하여 아스타잔틴 및 dha- 및/또는 epa-결합된 포스파티딜세린을 함유한 조성물을 제조하는 방법 및 이러한 방법에 의해 제조된 조성물
US10052319B2 (en) * 2012-04-26 2018-08-21 Sumitomo Dainippon Pharma Co., Ltd. Medicament for treating mental and behavioural disorders
AU2014360255B2 (en) * 2013-12-05 2017-07-27 Enzymotec Ltd. Serine glycerophospholipid preparation and method for treatment of seizures

Also Published As

Publication number Publication date
WO2016079595A3 (en) 2016-07-14
ES2745226T3 (es) 2020-02-28
AU2015348010A1 (en) 2017-07-13
JP6787891B2 (ja) 2020-11-18
CA2967895A1 (en) 2016-05-26
KR102409134B1 (ko) 2022-06-16
EP3220753A2 (en) 2017-09-27
IL252302B (en) 2021-04-29
CA2967895C (en) 2021-09-07
CN107249581B (zh) 2021-10-15
WO2016079595A2 (en) 2016-05-26
KR20170095246A (ko) 2017-08-22
EP3220753B1 (en) 2019-07-17
US20170360812A1 (en) 2017-12-21
JP2017536367A (ja) 2017-12-07
NZ733019A (en) 2021-12-24
CN107249581A (zh) 2017-10-13
AU2015348010B2 (en) 2020-02-27
IL252302A0 (en) 2017-07-31

Similar Documents

Publication Publication Date Title
IL286448A (en) auto-injector
EP3215153A4 (en) Immunoregulatory agents
EP3215142A4 (en) Immunoregulatory agents
EP3215141A4 (en) Immunoregulatory agents
EP3151820A4 (en) Immunoregulatory agents
EP3226856A4 (en) Combination therapies
EP3195630A4 (en) Geolocation-based pictographs
EP3129399A4 (en) Drug related transgene expression
EP3094351A4 (en) Immunomodulatory agents
EP3172262A4 (en) Silicone emulsions
EP3092008A4 (en) Skin probiotic
EP3184498A4 (en) Spacing-maintaining member
EP3237621A4 (en) Human alpha-galactosidase variants
EP3235493A4 (en) Preparation
PL3140189T3 (pl) Śmigłowiec
EP3187215A4 (en) Needless injector
EP3214112A4 (en) Member
EP3204042A4 (en) Psma-related therapies
EP3209559A4 (en) Aircraft
EP3145544A4 (en) Ang2 antibodies
EP3233895A4 (en) Anti-arrhythmicity agents
EP3094347A4 (en) Methods for enhancing the delivery of active agents
EP3226880A4 (en) Buchu preparations
EP3197470A4 (en) Cis-gnetin h and trans-gnetin h as therapeutic agents
IL252302B (en) Preparations of phospholipids to improve communication skills